Suchergebnisse - "Lee, W M"

PubPharm (23)

1

Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C

enthalten in: Journal of viral hepatitis | 2012

von Morishima, C. | Di Bisceglie, A. | Rothman, A. | +8

2

Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*

enthalten in: Journal of viral hepatitis | 2010

von Yuan, H. | Jain, M. | Snow, K. | +3

3

A randomized trial of high-dose interferon alpha-2b, with or without ribavirin, in chronic hepatitis C patients who have not responded to standard dose interferon

enthalten in: Alimentary pharmacology & therapeutics | 2002

von Malik, A. | Kumar, K. | Malet, P. | +6

4

Transforming growth factor-beta3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11

enthalten in: Endocrinology | 2001

von Lui, W. | Lee, W. | Cheng, C.

5

Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations

enthalten in: Cancer research | 2001

von Gee, M. | Saunders, H. | Lee, J. | +7

6

Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C

enthalten in: Hepatology (Baltimore, Md.) | 2001

von Reddy, K. | Wright, T. | Pockros, P. | +12

7

Chronic hepatitis B virus infection : treatment strategies for the next millennium

enthalten in: Annals of internal medicine | 2000

von Malik, A. | Lee, W.

8

Study on the formation of specialized inter-Sertoli cell junctions in vitro

enthalten in: Journal of cellular physiology | 1999

von Chung, S. | Lee, W. | Cheng, C.

9

Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12

enthalten in: Cancer research | 1999

von Gee, M. | Koch, C. | Evans, S. | +8

10

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

enthalten in: The New England journal of medicine | 1998

von McHutchison, J. | Gordon, S. | Schiff, E. | +7

CommentIn: N Engl J Med. 1998 Nov 19;339(21):1549-50. - PMID 9819457